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We performed this study to determine the effect on ocular blood flow and the electroretinogram of 
either nitric oxide synthase (NOS) inhibition, adenosine receptor blockade or the combination of 
both after I hr of ocular ischemia. Thirty-seven cats under general anesthesia were subjected to 
I hr of complete ischemia in one eye by raising the intraocular pressure above systolic blood 
pressure. The other eye in each animal served as a non-ischemic control. Arterial blood gas tension, 
systemic arterial pressure, body temperature, hematocrit, and anesthetic level were controlled in 
each experiment. Cats were divided into four groups. Group 1 received normal saline injections 
[intravenous (i.v.) and intravitreal], Group 2 adenosine receptor blockade (0.1 ml of 0.01 M 8- 
sulfophenyltheophylline intravitreal) and saline i.v., Group 3 NOS inhibition (30 mg/kg l-NG-nitro- 
arginine-methyi-ester i.v.) and saline intravitreal, and Group 4 intravitreai adenosine receptor 
blockade and NOS inhibition i.v. A subset of Group 3 received l-arginine to investigate the 
reversibility of NOS inhibition, after the blood flow measurements were completed. Five minutes 
after the end of ischemia, blood flows in retina and choroid were measured using injections of 
radioactively labeled microspheres. Electroretinographic (ERG) studies were carried out before 
treatment, before ischemia, during ischemia, and 1, 2, 3, and 4 hr after ischemia ended. NOS 
inhibition significantly reduced basal blood flow in the choroid, and in the retina when combined 
with adenosine receptor blockade. Adenosine receptor blockade completely attenuated post- 
ischemic hyperemia in the retina, but retinal hyperemia reappeared when adenosine receptor 
blockade and NOS inhibition were combined. Adenosine receptor blockade had no effect on ERG 
recovery after ischemia. NOS inhibition led to a reduction of ERG a- and b-wave amplitudes in 
control eyes, that could be reversed by l-arginine. Nitric oxide (NO) appears to be a significant 
factor in the regulation of basal blood flow in the choroid. Adenosine appears to be a major 
mediator of retinal hyperemia after 60 min of ischemia. Since NOS inhibition appeared to have 
direct effects on ERG wave amplitudes, short-term ERG studies may be of limited use in assessing 
the role of NO in postischemic recovery of the retina. Our observations correlate well with the 
emerging role of NO as a neurotrausmitter in the retina. © 1997 Elsevier Science Ltd 
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INTRODUCTION 
Pathological conditions uch as diabetic retinopathy or 
central retinal artery occlusion impair blood flow in the 
retina. Ocular blood flow is difficult to study in humans 
during these conditions, yet relatively few studies have 
been performed to investigate ocular blood flow in 
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experimental models comparable to these clinical situa- 
tions. We previously showed that ocular ischemia is 
followed by a significant increase (hyperemia) in retinal 
and choroidal blood flow (Roth & Pie~rzyk, 1994). 
However, little is known about the factors that mediate 
this increase in ocular blood flow after ischemia. 
Adenosine and nitric oxide (NO) are important 
vasoregulators found within the retina (Blazynski & 
Perez, 1991; Goldstein et al., 1996; Yarnamoto et al., 
1993). In previous studies we showed that inhibition of 
nitric oxide synthase (NOS) by intravenous (i.v.) 1- 
NAME (1-N°-nitro-arginine-methyl-ester) or intravitreal 
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injection of an adenosine receptor antagonist (8-sulfo- 
phenyltheophylline) partially diminished the degree of 
post-ischemic hyperemia in the retinal circulation after 
ocular ischemia in cats (Ostwald et al., 1995; Roth, 
1995). It also appeared that inhibition of NOS altered the 
ERG independent of the effect of ischemia (Ostwald et 
al., 1995); however, we did not assess the possible 
reversibility of this effect by administration f substrate 
(1-arginine). 
The effects of adenosine receptor blockade on post- 
ischemic retinal recovery are unknown; in a preliminary 
study, we found that an adenosine A1 receptor agonist 
improved ERG b-wave recovery after ocular ischemia in 
rabbits (Rosenbanm et al., 1992). In other preliminary 
studies, we have found significant increases in adenosine 
concentration during ischemia as well as in the early 
period of reperfusion following retinal ischemia (Roth et 
al., 1996a,b). These findings uggest that adenosine is of 
major importance in the retina's response to ischemia. 
Since both NO and adenosine are involved in post- 
ischemic hyperemia, blockade of adenosine r ceptors and 
NOS inhibition should ecrease post-ischemic hyperemia 
to a greater degree than with either maneuver alone. 
Simultaneous measurement of blood flow and the ERG 
could then provide insight into the role of post-ischemic 
hyperemia n retinal reperfusion i jury. 
A complicating factor in these studies is the effect on 
the circulation of the microspheres u ed to measure blood 
flow. Microspheres are a generally accepted and well 
described method to determine tissue blood flow, and 
their use allows simultaneous measurement of absolute 
values of retinal and choroidal blood flow, which is not 
possible with any other blood flow method at present 
(Alm et al., 1976; Buckberg et al., 1971; Heymann et al., 
1977). A disadvantage is the occurrence of artifactual 
changes in blood flow due to multiple microsphere 
injections (Roth & Pietrzyk, 1994). In this study, we 
avoided this problem by using only a single microsphere 
injection in each animal. 
METHODS 
Surgical preparation 
Procedures were approved by our Animal Care 
Committee and conformed to the ARVO Statement for 
Use of Animals in Ophthalmic and Vision Research. 
Adult cats were anesthetized with halothane and 
chloralose (80 mg/kg i.v.) and paralyzed with pancur- 
onium (0.2 mg/kg/hr i.v.). After tracheal intubation, the 
lungs were mechanically ventilated (Anesthesia Pediatric 
Ventilator, Air-Shields, Hatboro, PA); PaCO2 was 
maintained at 28-32 mmHg (normocarbia for cats) and 
PaO2 at 100-150 mmHg. Arterial blood gas tensions were 
determined using an ABL2 blood gas analyzer (Radio- 
meter, Copenhagen). Catheters were placed through 
groin incisions into bilateral femoral arteries (one 
catheter was advanced into the abdominal aorta for 
withdrawal of the reference blood sample) and into 
bilateral femoral veins. A left atrial catheter for micro- 
sphere injection was placed through a left thoracotomy. 
The anterior chamber of each eye was cannulated with a 
21-g needle and connected via a three-way stopcock to a 
pressure transducer [to measure intraocular pressure 
(IOP)] and to a saline reservoir (to increase IOP). 
Arterial blood pressure (mean arterial pressure =MAP), 
left atrial pressure, and IOP were continuously monitored 
(P23 transducers, Spectramed, Oxnard, CA) and recorded 
(2800S recorder, Gould, Cleveland, OH). Esophageal 
temperature and hematocrit (Hct) were measured and 
maintained constant, using a heating pad and infusion of 
previously removed autologous blood, respectively. 
During the study, esophageal temperature was 36.5- 
37°C. After surgical preparation was completed, ha- 
lothane concentration (measured with an Anesthetic 
Agent Analyzer, Puritan-Bennett, Datex Corp, Finland) 
was decreased to 0.2% expired. 
lschemia methodology and blood flow measurement 
Ocular ischemia was induced for 1 hr by elevation of 
IOP to 40 mmHg above systolic blood pressure in one 
eye of each animal (ischemic eye), as previously 
described (Ostwald et al., 1995). The other eye (control 
eye) was maintained at normal IOP. 
Retinal and choroidal blood flows in both eyes were 
measured by injecting 3 million 15/zm radioactively 
labeled microspheres (Nb 95 or Cel41, Dupont New 
England Nuclear, Wilmington, DE) into the left atrium 
5 rain after normal IOP was restored. A reference blood 
sample was withdrawn from the abdominal orta using a 
syringe pump (Model 22, Harvard Apparatus, Dover, 
MA) at 1.36 __+ 0.01 ml/min for 2 min starting 15 sec 
before microsphere injection. We have described this 
technique in detail previously (Ostwald et al., 1995; 
Roth, 1992a,b, 1995; Roth & Pietrzyk, 1994). In an 
earlier study, blood flows measured inpaired, identically 
treated eyes of the same animals were not significantly 
different (Roth, 1995). After completion of the experi- 
ments, radioactivity was counted in the different samples 
using a gamma counter (Minaxi Autogamma 5000 series, 
Packard, Downers Grove, IL). Blood flows (ml/100 g/ 
min) were calculated as previously described (Ostwald et 
al., 1995). 
Electroretinography 
Electroretinographic (ERG) measurements were per- 
formed after at least 40 min of dark adaptation and 
following pupil dilation with 0.5% tropicamide (Alcon, 
Humacao, Puerto Rico) and cyclomydril (0.2% cyclo- 
pentolate HCI and 1% phenylephrine HCI, Alcon, Fort 
Worth, TX). Full-field ERG responses to single white 
fashes lasting 10 #sec were recorded (Neuropack 8. 
Nihon Kohden, Irvine, CA). The photostimulator (Grass 
PS33C, Quincy, MA) was held at a distance of 20 cm 
from both eyes. Responses were detected with corneal 
contact lens electrodes (ERG-jet, Nicolet Biomedical, 
Madison, WI) with a scalp electrode as reference. 
Amplified signals (200 msec analysis time, 1-1500 Hzl 
were stored on computer disk, printed, and analyzed. 
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Recordings were performed at the following time points: 
before drug treatment (baseline), before ischemia, at 
5 min of ischemia, at 55 rain of ischemia and at 1, 2, 3, 
and 4 hr after ischemia ended. In control eyes, the ERG 
was recorded at the corresponding time points. ERG a- 
wave amplitude was measured from the baseline to the 
trough of the a-wave. ERG b-wave amplitude was 
measured from the trough of the a-wave to the peak of 
the b-wave. All amplitudes were normalized to baseline 
values and expressed as a percent of baseline. 
Protocols 
Cats were divided into four groups, and in each group 
the two eyes of each animal were treated identically as to 
drug or vehicle administration: Group 1 (n= 16) 
received 10 ml of normal saline (NS) solution i.v. and 
0.1 ml of NS solution (adjusted to physiological pH) 
intravitreal. Group 2 (n = 7) received 10ml of NS 
solution i.v. and 0.1 ml 0.01 M 8-sulfophenyltheophyl- 
line in NS (SPT, Research Biochemicals Inc., Natick, 
MA, adjusted to physiological pH) intravitreal. Group 3 
(n = 9) received 30 mg/kg 1-NC-nitro-arginine-methyl - 
ester i.v. (1-NAME, Sigma Chemicals, St. Louis, MO) 
dissolved in 10ml NS and 0.1 ml of NS solution 
(adjusted to physiological pH) intravitreal. Group 4 
(n = 5) received 30 mg/kg 1-NAME (in 10 ml NS) i.v. 
and 0.1 ml 0.01 M SPT in NS (adjusted to physiological 
pH) intravitreal. A subset of Group 3 (Group 3 I-ARG, 
n----4) received 200 mg/kg/hr 1-arginine i.v. (1-ARG, 
Sigma Chemicals, St. Louis, MO) after blood flow 
measurements were completed. 1-ARG was dissolved in 
NS solution and infused at a rate of 5 ml/hr, starting 
15 min after the end of ischemia (following blood flow 
measurement), until the end of the experinaent. After 
completion of all experiments, the anesthetized cats were 
killed by injection of KC1 into the left atrium. 
Drug dosing 
Both drugs or NS were given 60 min before induction 
of ischemia. NS or 1-NAME was infused i.v. over 30 min 
using a syringe pump (Model 22, Harvard Apparatus, 
Dover, MA). The intravitreal injections were adminis- 
tered into the mid-vitreous using a 0.5'% 27-g needle. In a 
previous study, injection of the same volumes of drug or 
diluent into the vitreous resulted in transient increases in 
IOP (Roth, 1995). To prevent these increases, and 
therefore avoid a possible "ischemic pre-conditioning" 
effect, we regulated lOP using the saline reservoir and 
three-way stopcock as described above. IOP was kept at 
10-15mmHg during and after injections into the 
vitreous. 
Dosing of i.v. or intravitreal agents was based upon 
results of previous experiments (Ostwald et al., 1995; 
Roth, 1995). SPT has been shown to have antagonistic 
effects on adenosine A1 and A2 receptors, although it is 
relatively A1 selective in rat brain (Bruns et al., 1980). 
Two hours elapsed between its intravitreal administration 
and blood flow measurements in order to allow sufficient 
diffusion of the drug through the vitreous. 
Statistical analysis 
All data are expressed as mean_SEM.  Variables 
within a group (i.e. control vs ischemic eyes) were 
compared using a paired t-test. Hemodynamic variables 
in Groups 2, 3, and 4 were compared to Gro~ap 1 using an 
unpaired t-test. Systat v 5.2 (SYSTAT, Inc., Evanston, 
IL) was used for analysis with P < 0.05 considered 
statistically significant. 
To compare blood flow results between Groups 1, 2, 3, 
and 4, we used analysis of variance (ANOVA, Stata, 
Stata Corp., TX). The F-test was used to drop factors that 
were not statistically significant from an initial model 
containing 1-NAME, SPT, and their interaction as 
variables (Fleiss, 1986; Snedecor & Cochran, 1980). 
The findings from ANOVA were further explored using 
t-testing, and P<0.05  was considered statistically 
significant. For each animal, the change in blood flow 
between control and ischemic eyes was calculated. We 
then used ANOVA to compare mean va][ues between 
groups for change in blood flow. 
Normalized ERG a- and b-wave amplitudes in Groups 
2, 3, 4, and 3 1-ARG were compared to Group 1 using an 
unpaired t-test with P < 0.05 considered statistically 
significant (Systat v 5.2, SYSTAT, Inc., Evanston, IL). 
TABLE 1. Mean arterial and ocular perfusion pressure, arterial blood gas tensions, Hct, and body temperature 5 min after ischemia ended 
Group 1 Group 2 Group 3 Group 4 
Intervention (i.v./intravitreal) NS/NS NS/SPT I-NAME/NS I-NAME/SPT 
n 16 7 9 5 
MAP (mmHg) 103 ___ 9 82 _+ 6 103 _+ 9 106 _+ 6 
OPP (mmHg) 88 _+ 9 67 +_ 6 88 _+ 9 91 +_ 6 
PaCO2 (mmHg) 30.9 _+ 1.0 31.6 ___ 1.0 29.9 + 0.9 30.3 _ 1.4 
PaO2 (mmHg) 141 _+ '.2 141 _ 4 144 _+ 6 142 + 5 
pH 7.39 _+ 0.01 7.39 +__ 0.01 7.40 _ 0.01 7.32 _+ 0.02* 
Hct(%) 32_2  28_+2 31 _+2 27_+4 
BT (°C) 37.0 + 0.1 36.9 _ 0.1 36.9 ___ 0.1 36.9 + 0.4 
Values are mean _ SEM; NS, normal saline; SPT, 8-sulfophenyltheophylline; I-NAME, l-NG-nitro-arginine-methyl-ester; n, number of cats; 
MAP, mean arterial pressure; OPP, ocular perfusion pressure (MAP-IOP); Hct, hematocrit; BT, body temperature. *P < 0.05 vs NS/NS- 
group. 
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FIGURE 1. Blood flow (mill00 g/min) in the retina (A), and choroid (B) in the eyes of cats 5 min after the end, of ocular 
ischemia for 60 rain. Data are displayed as mean ± SEM, and n indicates the number of cats in each group• One eye of each 
animal was ischemic; the other served as a non-ischemic control. Group l received normal saline solution i.v. and normal saline 
solution intravitreal. Group 2 received normal saline solution i.v. and 8-sulfophenyltheophylline (SPT) intravitreal. Group 3 
received 1-NG-nitro-arginine-methyl-ester (1-NAME) i.v. and normal saline solution intravitreal. Group 4 received I-NAME i.v. 
and SPT intravitreal. Statistical significance: *P < 0.05 for ischemic eyes compared to control eyes within the s~ane group; 
*P < 0.01 for ischemic eyes compared to control eyes within the same group; **P < 0.001 for ischemic eyes cc)mpared to 
control eyes within the same group. #Significant effect of 1-NAME on blood flow in control eyes (CoBF: 1 '< 0.009). 
§Significant effect of I-NAME and SPT in combination on blood flow in control eyes (RetBF: P < 0.03; CoBF: F' < 0.005). 
RESULTS 
Bloodflows 
Physiological parameters (MAP, arterial blood gas 
tensions, Hct, and body temperature) at the time of blood 
flow measurement are shown in Table 1. The only 
significant difference was that Group 4 had a lower pH 
than Group 1. 
Retinal blood flow values (RetBF) and statistically 
significant differences are shown in Fig. I(A). Differ- 
ences in blood flow values between control and ischemic 
eyes were significant in Groups 1, 3, and 4. There was a 
significant effect of the combination ofSPT and 1-NAME 
in Group 4 compared to Group 1 in control eyes. 
Furthermore, control RetBF in Group 4 was significantly 
less compared to that in Groups 2 and 3 (P < 0.02 and 
0.04, respectively), indicating a synergistic effect of the 
combination of SPT and 1-NAME. Mean change 
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(difference between control and ischemic eyes) in blood 
flow in Groups 1, 2, 3, and 4 was 16.7 ± 6.0, 
-15.3 _ 7.3, 25.6 +_ 7.0, and 17.3 ± 6.2 ml/100 g/min, 
respectively. Compared to Group 1, this change was 
significantly different in Group 2 (P < 0.004). 
Choroidal blood flow values (CoBF) and statistically 
significant differences are shown in Fig. I(B). Differ- 
ences in blood flow values between control and ischemic 
eyes were significant in all groups. There was a 
significant effect of 1-NAME on control CoBF in Group 
3 and of the combination ofSPT and 1-NAME in Group 4, 
compared to Group 1 in control eyes. Difference in 
control CoBF between Groups 2 and 4 was significant 
(P < 0.03), but not between Groups 3 and 4, indicating 
that the decreased control CoBF in Group 4 was due only 
to 1-NAME. Mean change in blood flow in Groups 1, 2, 3, 
and 4 was 716 ± 246, 1098 ± 373, 1251 +_ 146, and 
598 _+ 150ml/100g/min, respectively (not significant 
between groups). 
Electroretinography 
Two animals from Group 1 and one from Group 2 were 
excluded from the ERG data analysis because intravitreal 
hemorrhage d veloped after the end of ischemia. In those 
experiments hemorrhage was suspected frora a decrease 
in ERG wave amplitudes during the experiment and 
verified when eyes were dissected after the experiment 
for blood flow analysis. ERG a- and b-waw~ amplitudes 
expressed as a percent of baseline appear in Figs 2 and 3, 
respectively. Statistical differences between a- and b- 
wave amplitudes in the control and ischemic eyes of 
Groups 2, 3, 4, and 3 1-ARG compared to the respective 
eyes in Group 1 [Figs 2(A) and 3(A)I are indicated in Figs 
2(B-E) and 3(B-E). At nearly all time points, a- and b- 
wave amplitudes were significantly decreased in control 
eyes of Groups 3 and 4 compared to co~Ltrol eyes in 
Group 1, effects completely reversed by I-ARG [Figs 
2(E) and 3(E)]. At 2 and 4 hr after ischemia ended, a- 
wave amplitude was significantly decreased in Group 3 
ischemic eyes compared to ischemic eyes in Group 1, and 
FIGURE 2. Electroretinogram (ERG) a-wave amplitudes expressed as 
a percent of baseline. Data are displayed as mean+_ SEM, and n 
indicates the number of cats in each group. ERG was recorded at 
baseline, before ischemia, at 5 min of ischemia, at 55 rain of ischemia 
and 1, 2, 3, and 4 hr after the end of ischemia. One eye: of each animal 
was ischemic; the other served as a non-ischemic control. (A) Group 1 
received normal saline solution i.v. and normal saline solution 
intravitreal. (B) Group 2 received normal saline solution i.v. and 8- 
sulfophenyltheophylline (SPT) intravitreal. (C) Group 3 received l- 
N~-nitro-arginine-methyl-ester (I-NAME) i.v. and normal saline 
solution intravitreal. (D) Group 4 received 1-NAME i.v. and SPT 
intravitreal. (E) Group 3 1-ARG received 1-NAME i.v., normal saline 
solution intravitreal, and 1-arginine i.v. Statistical significance: 
*P < 0.05 for control eyes compared to control eyes in Group 1; 
*P< 0.01 for control eyes compared to control eyes in Group 1; 
**P < 0.001 for control eyes compared to control eyes in Group 1. 
#P < 0.05 for ischemic eyes compared to ischemic eyes in Group 1; 
§P < 0.001 for ischemic eyes compared to ischemic eyes in Group 1. 
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for the b-wave, at 2 and 3 hr after ischemia ended in 
Group 4 compared to Group 1. 
DISCUSSION 
In this study, NOS inhibition reduced basal blood flow 
in the choroid, and when combined with adenosine 
receptor blockade, in the retina as well. Adenosine 
receptor blockade completely attenuated post-ischemic 
hyperemia nthe retina, but retinal hyperemia reappeared 
when adenosine receptor blockade was combined with 
NOS inhibition. Hyperemia was unaltered by NOS 
inhibition. Adenosine receptor blockade did not alter 
ERG in ischemic or control eyes. NOS inhibition or the 
combination with adenosine receptor blockade signifi- 
cantly reduced a- and b-wave amplitudes incontrol eyes. 
1-ARG completely reversed the effects of NOS inhibition 
on a- and b-wave amplitudes in control eyes. 
Our present findings suggest hat adenosine is not 
involved in the regulation of basal vascular tone in the 
retina and confirm earlier observations by us and by 
others that adenosine is involved in the retinal vascular 
response to hypoxia or ischemia (Gidday & Park, 1993; 
Roth, 1995). However, in the present study the effect of 
SPT on postischemic retinal hyperemia was even more 
dramatic than in our previous tudy (Roth, 1995), where 
SPT resulted in partial attenuation of hyperemia. This 
difference is likely due to several differences in study 
design. Firstly, we allowed significan~;ly more time 
(>2 hr) for diffusion of SPT in the vitreous. Secondly, a
single microsphere injection was used to prevent 
artifactual changes in blood flow (Roth & Pietrzyk, 
1994), and thirdly, IOP was controlled 6uring and after 
intravitreal injections to prevent a possible "pre-con- 
ditioning" effect from transient elevations in lOP. 
Adenosine and its receptors have been found in the 
retina of different species (Blazynski et al., 1989a,b; 
Braas et al., 1987), and adenosine agonists decreased the 
release of excitatory amino acids from the ischemic brain 
(Simpson et al., 1992). In addition, neuroprotective 
effects of adenosine agonists have been shown by several 
investigators; for review see Rudolphi et al. (1992). In 
preliminary studies, we showed that an adenosine AI 
receptor agonist improved recovery of the ERG b-wave 
after ischemia in rabbits (Rosenbaum er al., 1992), and 
that adenosine concentration i  the retina increased not 
only during ischemia, but remained elewtted until 30 rain 
of reperfusion after 60 min retinal ischemia in rats (Roth 
et al., 1996a,b). 
Despite evidence suggesting an :involvement of 
adenosine in the vascular esponse to retinal ischemia, 
we could not detect any deleterious effects of adenosine 
blockade on the recovery of the ERG b-wave. The lack of 
effect of SPT on the ERG in our study could be due to 
incomplete receptor blockade. Yet we found complete 
attenuation of postischemic retinal hyperemia, implying 
FIGURE 3. Electroretinogram (ERG) b-wave amplitudes expressed as 
a percent of baseline. Other details as described in Fig. 2. 
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that adenosine receptors were likely antagonized. Our 
findings therefore may indicate that attenuation of 
hyperemia does not alter outcome. However, this 
potentially important inference must be viewed cau- 
tiously, as our follow-up period was only until 4 hr after 
ischemia concluded, and furthermore, the ERG may be 
insufficiently sensitive as an outcome measurement. 
Effects of hyperemia, such as retinal edema or other 
forms of delayed reperfusion injury, may not become 
evident until much later in the post-ischemic time course. 
Future studies to assess the impact of hyperemia on 
retinal injury should be performed using more sensitive 
measurements during a longer post-ischemic follow-up 
time. 
The role of NO in retinal physiology has been reviewed 
by us recently elsewhere (Goldstein et al., 1996). In a 
previous tudy in cats, NOS inhibition did not result in a 
significant reduction of basal blood flow in the retina, and 
a trend for decrease in basal choroidal flow did not reach 
statistical significance (Ostwald et al., 1995). In the 
present study we found that NOS inhibition reduced basal 
blood flow in the choroid. This may have in part been due 
to a generally lower MAP in the previous tudy. We used 
a greater number of animals in the present study in 
combination with an improved statistical analysis. The 
greater sample size may explain the ability to demon- 
strate statistical significance in the present study. 
Methodological error is an unlikely probability, since 
retinal and cerebral blood flow (latter data not shown) 
were similar in the two studies. That the effect of 1- 
NAME was more pronounced in the choroid compared to 
the retina would be expected; NOS-containing nerve 
fibers derived predominantly from the pterygopalatine 
ganglion heavily innervate the choroidal blood vessels, 
especially in the temporal-central egion, in both rat and 
human eyes (Fltigel et al., 1994; Yamamoto et al., 1993). 
The combination of NOS inhibition and adenosine 
receptor blockade produced a synergistic decrease in 
basal blood flow in the retina. While some have theorized 
that adenosine and NO may interact in the vasculature, or 
that one may serve as a messenger to produce the other's 
effects (Dirnagl et al., 1994), this synergistic effect upon 
basal blood flow has not been previously demonstrated in 
vivo. 
In our earlier study, three of nine 1-NAME-treated cats 
had no hyperemia. Others have also found inconsistency 
in the postischemic hyperemia phenomenon (Takeshima 
et al., 1994), perhaps the result of severe endothelial or 
other damage in the vasculature, depletion of vasodila- 
tory substances, thrombosis, or vasospasm. However, 
hyperemia was seen consistently in the 1-NAME group in 
the present study, and all three statistical comparisons 
showed no effect of 1-NAME on basal or postischemic 
RetBF. Inclusion of the non-hyperemic animals in the 
earlier study is the most probable reason for the findings 
of decreased hyperemia in the 1-NAME treated group in 
the previous study. It is most likely that the present 
findings are accurate and reliable, and reflect a minor role 
for NO in the postischemic RetBF response, in contrast to 
the sim~Imaeously demonstrated major role of adeno- 
sine. 
We observed the striking phenomenon that retinal 
hyperemia was blocked by adenosine receptor blockade, 
not altered by NOS inhibition, but reappeared when 
adenosine receptor blockade and NOS inhibition were 
combined. With the assumption that adenosine is the 
main mediator of postischemic retinal hyperemia, we 
theorized that NOS inhibition may have increased retinal 
adenosine concentration to an extent sufficient o over- 
come competitive adenosine receptor blockade with SPT. 
That NOS inhibition could increase adenosine concen- 
tration is supported by an observation in coronary 
arteries. Kostic and Schrader (1992) found that 60 sec 
of coronary ischemia in the isolated guinea pig heart was 
followed by reactive hyperemia nd by an increase of 
adenosine and NO concentrations. Inhibition of NOS by 
1-NAME significantly increased adenosine release under 
basal and postischemic onditions. This effect was 
enhanced when oxyhemoglobin, a potent scavenger of 
NO, was given in addition to 1-NAME, while d-NAME, 
the stereoisomer of 1-NAME, had no effect on adenosine 
concentrations. A similar effect of NOS inhibition on 
postischemic adenosine concentrations in the retina could 
explain the observation that combined NOS inhibition 
and adenosine receptor blockade resulted in retinal 
hyperemia. 
Little is known about he effect of NO donors or NOS 
inhibition on the ERG in vivo. The NO donor sodium 
nitroprusside (SNP) or NOS inhibitor nitro-lt-arginine (I-
NA) were administered intravitreally to rabbits (Veriac et 
al., 1993), but the effect of either treatment o:a the ERG b- 
wave amplitude was not described. Maynard et al. 
(1995), studying isolated rabbit retina, found an effect 
of NOS inhibition only on compound action potentials 
from the optic nerve, but not from the Pill component, 
supposed to represent he photoreceptor activity. We 
found that NOS inhibition significantly reduced the ERG 
a- and b-wave amplitudes in control eyes in those groups 
that received 1-NAME or 1-NAME and SPT. The effect of 
1-NAME could be reversed by 1-ARG, indicating the 
specific involvement of NOS. Similar, although less 
dramatic, results have recently been found by us in the 
intact rat retina (Rosenbaum et al., 1996). The latter 
findings suggest hat the effect of NOS inhibition on 
retinal electrophysiological function may, in part, be 
species dependent. Our observations are the first to 
suggest arole of NO in visual transduction i the retina in 
intact vertebrate animals. Since NOS inhibition de- 
creased choroidal but not RetBF, it is pos~dble that the 
ERG effects we found were partially related to decreased 
blood flow; therefore, our study cannot completely 
distinguish between possible neural- or vascular- 
mediated mechanisms of action of NOS :inhibition on 
the cat retina. 
The ERG a-wave is generated in photoreceptors 
(Tomita & Yanagida, 1981). A decrease in a-wave 
amplitude due to NOS inhibition is consistent with the 
findings that 1-ARG and SNP altered light responses and 
3460 P. OSTWALD et al. 
dark voltage in isolated frog rods (Schmidt et al., 1992; 
Tsuyama et al., 1993). NOS is coupled to a soluble 
guanylate cyclase in photoreceptors (Koch et al., 1994) 
and cGMP-gated cation channels in these cells are 
responsible for the dark current (Fesenko et al., 1985; 
Lagnado & Baylor, 1992), Hence, NOS inhibition could 
have decreased cGMP concentrations and thereby altered 
the dark current. Since cGMP-independent effects of NO 
on Ca 2+ currents in photoreceptors have also been shown, 
another mechanism may be that NOS inhibition inter- 
fered with synaptic transmission (Kurenny et al., 1994). 
Reversal of the effect of 1-NAME using an excess of 1- 
ARG may have resulted in an increased synthesis of NO. 
Interestingly, we found that application of 1-ARG 
significantly increased the ERG a-wave at the "2 hr" 
and "3 hr" time point in control eyes which may be due to 
increased NO levels. 
The ERG b-wave is believed to represent light-evoked 
depolarizations in ON-bipolar cells (Stockton & Slaugh- 
ter, 1989), which contain an NO-sensitive soluble 
guanylate cyclase (Shiells & Falk, 1992a). Similar to 
photoreceptors, they also contain a cGMP-gated cation 
channel (Shiells & Falk, 1992b). Depolarization of ON- 
bipolar cells in response to photoreceptor light responses 
is mediated by this cGMP-gated ion channel (Nawy & 
Jahr, 1990, 1991). Since ON-bipolar cells are not known 
to contain NOS, the NO which may act upon them is 
likely generated in adjacent amacrine cells (Koistinaho et 
al., 1993). Hence, a possible xplanation for the effects of 
NOS inhibition on ERG b-wave amplitudes that we 
observed could be that synaptic transmission within the 
inner retina was altered. 
Effects of NOS inhibition on visual transduction and 
on ERG wave amplitude render it difficult to differentiate 
the depressant effects of NOS inhibition on visual 
transduction from the effect of retinal damage itself. 
Furthermore, NOS inhibition has been used as a 
treatment of septic shock in patients (Petros et al., 
1991; Billiar, 1995). The striking effects of NOS 
inhibition on the ERG that we observed suggest the need 
for caution in initiating such therapy. For future 
investigations on retinal outcome after ischemia using 
NO donors or NOS inhibition, simultaneous histologic 
studies may be of additional value (Hughes, 1991). In our 
study, eye tissues were needed for blood flow analysis 
and could not be used for histologic evaluation. 
In summary we found the following effects of 
adenosine receptor blockade and NOS inhibition on 
ocular blood flow and the electroretinogram: 
1. NOS inhibition decreased basal CoBF, and the 
combination of NOS inhibition and adenosine 
receptor blockade produced synergistic decreases 
in RetBF. 
2. Adenosine receptor blockade completely attenuated 
postischemic hyperemia in the retina. 
3. The combination of adenosine receptor blockade 
and NOS inhibition had effects on control and post- 
ischemic RetBF that indicate interactions between 
adenosine and NO. 
4. NOS inhibition reduced ERG a- and b-wave 
amplitudes in control eyes, an effect completely 
reversed by 1-arginine, indicating that NO is likely 
involved in visual transduction processes in verte- 
brate animals. 
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